An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU) (B7451084) First published 30/10/2024 Last updated 11/11/2025 EU PAS number:EUPAS1000000282 Study Ongoing